Substance Abuse/Addiction

The Youth-Nominated Support Team intervention invites adolescents to select adults in their life to receive training on how to support them.

New research examines important factors of adherence when prescribing exercise to treat depression.

In 2014, then National Institute of Mental Health (NIMH) director, Thomas Insel, speculated that ketamine “might be the most important breakthrough in antidepressant treatment in decades.” A recent review of the research suggests that while ketamine may produce a rapid short-term improvement in depression, the effect is short-lived and the potential for addiction and dependence warrants considerable caution.

An equal percentage of young people will start misusing ADHD-related and other stimulant drugs for the first time at age 13 as will start at age 20.

A new study examines the extent to which patterns in prescription drug misuse and substance use disorder symptoms can be predicted by education level

A recent review found that hypnotic medications are associated with risks of suicide and suicidal ideation.

New research published in JAMA Pediatrics reveals that transgender women have more than double the prevalence of psychiatric diagnoses than the general US population. The study found that the women, who had been assigned male at birth and now identified as female, had a high prevalence of suicidality, post-traumatic stress disorder, substance abuse, generalized anxiety and major depressive disorder.

An international study of college students reveals ubiquitous social and emotional challenges faced by young adults.

Two new articles find that rates of ADHD diagnosis and stimulant prescription continue to rise all over the world.

More than ten-percent of adults in the United States are currently prescribed at least one psychiatric medication but there is currently a lack of research on the prevalence of adverse drug events (ADEs) associated with these prescriptions outside of clinical trials.

This month’s issue of JAMA Psychiatry ran an editorial commenting on recent research revealing that the majority of youth prescribed antipsychotics have not been diagnosed with a mental disorder.

A recent article in the American Journal of Public Health calls for policy level interventions to reduce the use of benzodiazepines, drugs commonly prescribed...

New research demonstrates that children diagnosed with ADHD at younger ages are more likely than those diagnosed later to receive multiple medications within five years of their diagnosis.

Researchers find that support and self-care were helpful for users during discontinuation, but that mental health professionals were not very helpful.

A new study suggests that smoking cessation is related to depressive symptom improvement, but that depression may also make it harder to quit.

ServiceNet, a mental health and human service agency in western Massachusetts, received a three year, two million dollar grant to launch a program designed to support young adults who have recently experienced their first episode of psychosis. The Prevention and Recovery Early Psychosis (PREP) program is funded by the Massachusetts department of mental health and is designed to treat psychosis as a symptom, not an illness, resulting from other illnesses, substance abuse, trauma, or extreme stress.

Research examines the effects of cognitive behavioral therapy (CBT) on experiences of chronic pain among low-income patients.

Twice as many teenagers with ADHD experienced severe psychosis when taking Adderall, as compared to Ritalin, according to a new study.

A former pharma executive has broken ranks with the industry in a new book by reporting how multiple psychiatrists, schools, and his desperate hopes pressed him to allow higher and higher doses of antipsychotic medications. The result: his 15-year-old son's death from Seroquel.

A new study examines longitudinal, intergenerational patterns associated with marijuana use.

A Johns Hopkins Bloomberg School of Public Health survey of 1000 US primary care physicians found that many do not understand basic medical facts about the addictive nature of the opioids they are prescribing.

The Commission was addressed by organizations engaged with various aspects of addiction treatment. Much of the input seemed apropos, but one voice was missing. Speakers failed to include even one practicing physician or advocate for the pain patients who have been blamed for the so-called “opioid epidemic.”

“Converging lines of evidence now suggest that depression—a common comorbidity in the setting of chronic pain—may in some patients represent an unrecognized yet potentially reversible harm of opioid therapy.”

MIA Foreign Correspondent Peter Gøtzsche, author of the book Deadly Medicines and Organised Crime, was interviewed on Comedy Central's The Daily Show with Jon...

Bertha Madras, professor of psychobiology at Harvard Medical School, has printed a critique listing 20 flaws to a recent study finding no differences in physical or mental health problems between users and non-users of marijuana.